Slideshow

MS and Natalizumab: 3 New Findings

Three brand new studies shed light on use of natalizumab in relapsing-remitting multiple sclerosis.

Natalizumab is a highly effective therapy for relapsing-remitting multiple sclerosis. However, its efficacy in the context of other more recently available treatments needs to be assessed. Further, hampering the long-term of use of natalizumab is the association of treatment with a risk of progressive multifocal leukoencephalopathy (PML).The slides above highlight findings of 3 new studies of natalizumab.   

Related Videos
Kathleen Costello, CRNP, MSCN
Christian Cordano, MD, PhD
Jack P. Antel, M D
Sarah Levy, PhD
Enrique Alvarez, MD, PhD
Ceren Tozlu, PhD
Cristin Welle, PhD
Patricia K. Coyle, MD
© 2025 MJH Life Sciences

All rights reserved.